Health
Breakthroughs and beating the odds.
Cambridge Completes First Human Trial of Sarbecovirus Vaccine
Researchers at the University of Cambridge completed the first human trial of an AI-designed vaccine targeting sarbecoviruses.
UCLA trial shows promising results for off-the-shelf cancer vaccine
A new off-the-shelf cancer vaccine targeting KRAS mutations shows strong immune responses in pancreatic and colorectal cancer patients.
Chile eliminates leprosy and rabies as public health problems
Chile has been recognized for eliminating leprosy and dog-transmitted rabies, achieving major public health milestones.
Thailand eliminates rubella as a public health concern
Thailand has successfully eliminated rubella, recognized by WHO as a major milestone in public health.
Pfizer-Valneva Lyme disease vaccine shows 73.2% efficacy in trial
The investigational Lyme disease vaccine PF-07307405 demonstrates 73.2% efficacy in a phase 3 trial.
Optogenetic therapy enhances vision in patients with retinitis pigmentosa
A clinical study shows optogenetic therapy improved light sensitivity in 10 patients with advanced retinitis pigmentosa.
FDA Approves Ensitrelvir as First Oral COVID-19 Prophylaxis
The FDA has approved ensitrelvir, the first oral medication for post-exposure prevention of COVID-19, effective for adults and adolescents.
51.2 Million Lives Saved in Africa Through Expanded Immunisation
Over 51 million lives have been saved in Africa due to vaccines under the Expanded Programme on Immunisation.
Phase 1 Trial Shows Promising Results for KRAS Vaccine in Cancer
A trial of the ELI-002 2P vaccine showed 84% of patients developed strong immune responses.
GSK's Bepirovirsen Achieves Functional Cure in Hepatitis B Trials
GSK's drug bepirovirsen achieved a functional cure in 19% of participants in Phase 3 trials.
Gene Therapy Shows High Success Rate for Children with ADA-SCID
A gene therapy trial successfully restored immune function in 48 of 50 children with ADA-SCID, offering new hope for treatment.
FDA approves first gene therapy for severe leukocyte adhesion deficiency-I
The FDA has approved Kresladi, a groundbreaking gene therapy for severe leukocyte adhesion deficiency-I, developed at UCLA.
Malaria Vaccine RTS,S Averts 1 in 8 Child Deaths in Pilot Countries
The RTS,S malaria vaccine has significantly reduced child mortality, averting 1 in 8 deaths in Ghana, Kenya, and Malawi.
Gavi Vaccination Programs Yield $30 Billion Economic Benefits in 2025
Gavi's vaccination efforts generated over $30 billion in economic benefits in 2025, immunizing 73 million children.
Roswell Park Trial Shows Cancer Vaccine Improves Glioblastoma Survival
Roswell Park Comprehensive Cancer Center reports promising results from a cancer vaccine trial, extending survival for glioblastoma patients.
FDA approves ensitrelvir as first oral antiviral for COVID-19 prevention
The FDA has approved ensitrelvir as the first oral antiviral for post-exposure prophylaxis against COVID-19 in the U.S.
Caitlin Clark shines in WNBA and World Cup 2026
Caitlin Clark achieved career-best statistics in the 2026 WNBA season and contributed to Team USA's World Cup gold.
New Method Targets Gum Disease Without Killing Beneficial Bacteria
A novel approach disrupts harmful bacterial signals to improve oral health without harming beneficial bacteria.
Gene Therapy Shows 95% Success in Treating ADA-SCID in Children
A UCLA-led study found gene therapy restored immune function in 59 of 62 children with ADA-SCID, a rare genetic disorder.
Vitamin C Trial Shows Reduced Deaths in Blood Disorder Patients
A phase 2 trial found vitamin C linked to fewer deaths and complications in patients with blood disorders.
Stanford Researchers Discover Method to Regrow Cartilage in Mice
Stanford scientists found a way to regrow knee cartilage in aged mice by blocking an age-related protein.
Gene Therapy Successfully Restores Hearing in Children
Otarmeni, the first FDA-approved gene therapy for deafness, has restored hearing in many children with OTOF mutations.
Johns Hopkins Vaccine mKRAS-VAX Demonstrates Durable Immune Response in Pancreatic Cancer Trial
The mKRAS-VAX vaccine shows durable T-cell responses in 90% of participants in a pancreatic cancer trial, with no cancer development.
UCLA gene therapy shows 95% success in ADA-SCID treatment
A UCLA-led study reveals 95% success in restoring immune function in children with ADA-SCID through gene therapy.
FDA Approves First Oral Antiviral for COVID-19 Prevention
The FDA has approved ensitrelvir (Xocova) for COVID-19 post-exposure prophylaxis, showing a 67% reduction in symptomatic infections.
500 rural health facilities in Madagascar receive solar power
Madagascar's 500 rural health facilities now have reliable solar power for nighttime care and vaccine refrigeration.
Eight-week hepatitis C treatment shows 98.8% cure rate
A study found an eight-week hepatitis C regimen cures 98.8% of patients, nearly matching the standard 12-week treatment.
India approves Takeda's dengue vaccine Qdenga for ages 4 to 60
India has approved its first dengue vaccine, Qdenga, showing 80.2% efficacy against symptomatic dengue.
India introduces CRISPR therapy BIRSA 101 for sickle cell disease
India has launched BIRSA 101, its first indigenous CRISPR-based gene therapy for sickle cell disease, developed by CSIR-IGIB.
CRISPR Therapy CTX310 Reduces LDL Cholesterol by Over 50 Percent for One Year in Trial
A single infusion of the CRISPR-Cas9 therapy CTX310 achieved significant and sustained reductions in LDL cholesterol and triglycerides during a Phase 1a clinical trial for lipid disorders.
Ensitrelvir shows 67% reduction in COVID-19 risk in trial
Ensitrelvir reduced the risk of symptomatic COVID-19 by 67% in a phase 3 trial, aiding high-risk participants significantly.
WHO Reviews Malaria Vaccine Pipeline with Two Prequalified
WHO's review identifies two prequalified malaria vaccines among 147 candidates, advancing global health efforts.
GSK and Ionis Report Successful Hepatitis B Treatment Trial
GSK and Ionis announced a 19% functional cure rate for hepatitis B with their drug bepirovirsen in Phase 3 trials.
Gene-editing therapy shows significant promise for sickle cell disease
A clinical trial found that 27 of 28 participants treated with reni-cel gene therapy had no vaso-occlusive crises.
USF Health Discovers New Malaria Vaccine Target
Researchers at USF Health identify a new vulnerability in the malaria parasite for potential vaccine development.
Bepirovirsen shows 19% functional cure rate in hepatitis B trials
GSK's bepirovirsen shows promising results with a 19% functional cure rate for chronic hepatitis B.
Moderna and Merck Report Positive Phase 3 Results for mRNA Cancer Vaccine
Moderna and Merck's mRNA cancer vaccine shows promise in reducing melanoma recurrence in a Phase 3 trial.
Multistage Malaria Vaccine Shows Favorable Early Trial Results
A new malaria vaccine demonstrated a favorable safety profile in early human trials, showing promising protective efficacy.
UCLA Trial Reports Strong Results for Off-the-Shelf Cancer Vaccine
A new cancer vaccine shows promise in patients with pancreatic and colorectal cancer, enhancing immune responses against KRAS mutations.
University of Cambridge Completes First Human Trial of Sarbecovirus Vaccine
Cambridge researchers completed a human trial of pEVAC-PS, an AI-designed vaccine against sarbecoviruses, showing safety and modest immune responses.
In vivo CAR-T therapy shows promise for multiple sclerosis
A clinical trial found that in vivo CAR-T therapy improved symptoms in participants with multiple sclerosis and autoimmune conditions.
WHO Launches Childhood Cancer Survival Data Portal
WHO releases first global survival estimates for childhood lymphoid leukaemia across 194 countries.
Timor-Leste Achieves Elimination of Trachoma as Health Problem
Timor-Leste has been validated by WHO for eliminating trachoma, the leading infectious cause of blindness.
Moderna and Merck's mRNA Melanoma Vaccine Shows Success in Trial
Moderna and Merck's personalized mRNA vaccine met key endpoints in a Phase 3 trial for melanoma treatment.
Wolbachia Mosquito Release Reduces Dengue Cases by Over 70%
A trial in Singapore shows Wolbachia-infected mosquitoes cut dengue risk by 71-72% among over 700,000 residents.
WRSs2 Shigella vaccine shows 89% protection in trial
A trial of the WRSs2 Shigella vaccine achieved 89% efficacy with two doses, the highest for any candidate.
Big Catch-Up initiative delivers over 100 million childhood vaccine doses
The Big Catch-Up initiative successfully delivered over 100 million vaccine doses to millions of children across 36 countries.
Rotavirus vaccine significantly reduces gastroenteritis deaths
Rotavirus vaccination reduces mortality from gastroenteritis by 75.8% in children, according to a global study.
Thailand achieves rubella elimination as a public health problem
Thailand has been verified by WHO for eliminating rubella as a public health issue as of September 2026.
FDA approves CRISPR gene therapy Casgevy for children 2+
The FDA has approved Casgevy for children 2 and older with sickle cell disease or β-thalassemia.